Agitation in the Acute Psychiatric Department
1 other identifier
observational
384
1 country
1
Brief Summary
Agitation is associated with a number of acute psychiatric conditions, and frequent in acute psychiatric admissions. It is associated with violence towards others, and strongly associated with in-patient suicides. The main aims of the study are to assess different clinical presentations of agitation at admittance, and to assess the consequences of these different clinical presentations during the first three days of the stay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2011
CompletedFirst Posted
Study publicly available on registry
August 11, 2011
CompletedStudy Start
First participant enrolled
September 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedNovember 19, 2024
November 1, 2024
6 months
July 6, 2011
November 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the number of violent or threatening incidents the first three days of inpatient stay measured with The Staff Observation Aggression Scale - Revised (SOAS-R) with positive scorings of incidents with a severity score >8.
Up to 4 years.
Secondary Outcomes (1)
the degree of suicidal intention the first three days of inpatient stay measured with the 10 item self-rating VAS-scale administered at discharge from the acute department.
Up 4 years
Study Arms (1)
Acutely admitted psychiatric in-patients
Eligibility Criteria
All acutely admitted psychiatric in-patients from a defined catchment area.
You may qualify if:
- All consecutive acutely admitted in-patients are asked for participation.
You may not qualify if:
- Patients not willing to sign informed consent form.
- Patients not speaking English or Norwegian.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- University of Bergencollaborator
- University of Oslocollaborator
- Deakin Universitycollaborator
Study Sites (1)
St Olavs University Hospital, Department of Acute Psychiatry Østmarka
Trondheim, 7441, Norway
Related Publications (3)
Sallaup TV, Vaaler AE, Iversen VC, Guzey IC. Challenges in detecting and diagnosing substance use in women in the acute psychiatric department: a naturalistic cohort study. BMC Psychiatry. 2016 Nov 17;16(1):406. doi: 10.1186/s12888-016-1124-y.
PMID: 27855664RESULTNakken EI, Grinde F, Vaaler A, Drange OK, Brodtkorb E, Saether SG. Epilepsy and other seizure disorders in acute psychiatric inpatients. BMC Psychiatry. 2021 Dec 15;21(1):626. doi: 10.1186/s12888-021-03619-y.
PMID: 34911471RESULTKrane-Gartiser K, Vaaler AE, Fasmer OB, Sorensen K, Morken G, Scott J. Variability of activity patterns across mood disorders and time of day. BMC Psychiatry. 2017 Dec 19;17(1):404. doi: 10.1186/s12888-017-1574-x.
PMID: 29258468DERIVED
Biospecimen
Blood samples are collected for storage and analyses both at admittance and discharge from the psychiatric acute department.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Arne E Vaaler, PhD, MD
Norwegian University of Science and Technology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2011
First Posted
August 11, 2011
Study Start
September 1, 2011
Primary Completion
March 1, 2012
Study Completion
March 1, 2012
Last Updated
November 19, 2024
Record last verified: 2024-11